miR-137 and miR-491 Negatively Regulate Dopamine Transporter Expression and Function in Neural Cells

The schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function

(2017) Nikkie F.M. Olde Loohuis et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The effects of DAT1 genotype on fMRI activation in an emotional go/no-go task

(2016) Brenna K. Brown et al.   Brain Imaging and Behavior

Meta-analysis of the association of the SLC6A3 3′-UTR VNTR with cognition

(2016) Ulrich Ettinger et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Non-coding RNAs as Emerging Regulators of Neural Injury Responses and Regeneration

(2016) Songlin Zhou et al.   Neuroscience Bulletin

miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells

(2016) Mathieu Neault et al.   Cell Reports

microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator

(2015) Huajun Jiang et al.   ATHEROSCLEROSIS

A 40-bp VNTR polymorphism in the 3′-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism

(2015) Omar Šerý et al.   Behavioral and Brain Functions

A variable number of tandem repeats in the 3′-untranslated region of the dopamine transporter modulates striatal function during working memory updating across the adult age span

(2015) Fabio Sambataro et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2

(2015) Jie Sun et al.   JOURNAL OF NEURO-ONCOLOGY

Detection of auto-antibodies to DAT in the serum: Interactions with DAT genotype and psycho-stimulant therapy for ADHD

(2015) Grazia Giana et al.   JOURNAL OF NEUROIMMUNOLOGY

Brain Region-Specific Trafficking of the Dopamine Transporter

(2015) E. R. Block et al.   JOURNAL OF NEUROSCIENCE

Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studies

(2015) S. Nikolaus et al.   NUKLEARMEDIZIN-NUCLEAR MEDICINE

The association of polymorphisms in DAT (40 bp VNTR, C>T 3′UTR) and DBH (−1021 C/T) genes with the severe complications of alcohol withdrawal state

(2015) Dmitriy V. Ivashchenko et al.   PSYCHIATRIC GENETICS

Association between the dopamine transporter gene (DAT1) and attention deficit hyperactivity disorder-related traits in healthy adults

(2015) Seong Hoon Jeong et al.   PSYCHIATRIC GENETICS

Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter

(2015) Mary Hongying Cheng et al.   STRUCTURE

Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing

(2015) Jubao Duan   Neuroscience Bulletin

Dopaminergic modulation of synaptic plasticity in rat prefrontal neurons

(2015) Satoru Otani et al.   Neuroscience Bulletin

The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer

(2015) Guopei Zheng et al.   Oncotarget

MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets

(2014) M Strazisar et al.   MOLECULAR PSYCHIATRY

Crack Cocaine Users Show Differences in Genotype Frequencies of the 3′ UTR Variable Number of Tandem Repeats of the Dopamine Transporter Gene (DAT1/SLC6A3)

(2014) Anderson Ravy Stolf et al.   NEUROPSYCHOBIOLOGY

Methylphenidate Effects on Brain Activity as a Function of SLC6A3 Genotype and Striatal Dopamine Transporter Availability

(2014) Anna-Maria Kasparbauer et al.   NEUROPSYCHOPHARMACOLOGY

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma

(2014) X Li et al.   ONCOGENE

Association between the 9 repeat allele of the dopamine transporter 40bp variable tandem repeat polymorphism and Alzheimer’s disease

(2014) Ágnes Fehér et al.   PSYCHIATRY RESEARCH

Association of a miRNA-137 Polymorphism with Schizophrenia in a Southern Chinese Han Population

(2014) Guoda Ma et al.   Biomed Research International

MicroRNAs 185, 96, and 223 Repress Selective High-Density Lipoprotein Cholesterol Uptake through Posttranscriptional Inhibition

(2013) L. Wang et al.   MOLECULAR AND CELLULAR BIOLOGY

SLC6 transporters: Structure, function, regulation, disease association and therapeutics

(2013) Akula Bala Pramod et al.   MOLECULAR ASPECTS OF MEDICINE

Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: On the path to an animal model of attention-deficit hyperactivity disorder

(2013) Marc A. Mergy et al.   NEUROCHEMISTRY INTERNATIONAL

Inhibition of Dopamine Transporter Activity by G Protein βγ Subunits

(2013) Jennie Garcia-Olivares et al.   PLoS One

The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens

(2013) Clara Velázquez-Sánchez et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Mechanisms of dopamine transporter regulation in normal and disease states

(2013) Roxanne A. Vaughan et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Dopamine Signaling in reward-related behaviors

(2013) Ja-Hyun Baik   Frontiers in Neural Circuits

Modulation by Cocaine of Dopamine Receptors through miRNA-133b in Zebrafish Embryos

(2012) Katherine Barreto-Valer et al.   PLoS One

Proteins Interacting with Monoamine Transporters: Current State and Future Challenges

(2011) Jonathan J. Sager et al.   BIOCHEMISTRY

Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue

(2011) Yongfang Zhao et al.   NATURE

Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges

(2010) Jacob Eriksen et al.   JOURNAL OF NEUROCHEMISTRY

Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction

(2007) Richard B. Rothman et al.   BIOCHEMICAL PHARMACOLOGY